Stay updated on PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial
Sign up to get notified when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.

Latest updates to the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRecord History shows Revision: v3.6.5, replacing v3.6.4. This reflects a minor platform release update to the history page rather than any substantive changes to the trial information.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe Study Record Versions history now shows Revision: v3.6.4, indicating a new platform release for the page. This update is a metadata version change and does not alter the trial data or visible content.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry, v3.6.3, was added to the study's record history, and the previous revision, v3.6.2, was removed from the list.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study record history now includes a new revision entry for v3.6.2, following the previous v3.6.0 entry, signaling an administrative update to the record.SummaryDifference0.1%

- Check72 days agoChange DetectedThe record history adds the Last verified and Last known status was fields. It also updates the revision label to v3.6.0, replacing v3.5.5.SummaryDifference3%

- Check79 days agoChange DetectedA new revision entry (v3.5.5) was added to the record history, replacing the previous revision (v3.5.4).SummaryDifference0.1%

Stay in the know with updates to PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.